Overview
Alexandre Rouette practices in Montreal, Canada. Mr. Rouette is rated as an Advanced expert by MediFind in the treatment of Acute Megakaryoblastic Leukemia. His top areas of expertise are Acute Megakaryoblastic Leukemia, Acute Myeloid Leukemia (AML), Leukemia, and Retinoblastoma.
His clinical research consists of co-authoring 20 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Acute Megakaryoblastic Leukemia.
Locations
Montreal, QC, Canada
Quebec, QC, Canada
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acute Megakaryoblastic LeukemiaMr. Rouette isAdvanced. Learn about Acute Megakaryoblastic Leukemia.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Mr. Rouette isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myeloid Leukemia (AML)Mr. Rouette isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Exocrine Pancreatic InsufficiencyMr. Rouette isExperienced. Learn about Exocrine Pancreatic Insufficiency.
- FibrosarcomaMr. Rouette isExperienced. Learn about Fibrosarcoma.
- LeukemiaMr. Rouette isExperienced. Learn about Leukemia.
- RetinoblastomaMr. Rouette isExperienced. Learn about Retinoblastoma.